Company / EPS (Diluted)
Arcellx, Inc. EPS (Diluted) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.47
FY2025
5-year range
-$145.55 / -$1.47
FY2021-FY2025
Trend
+71.7%
vs FY2024
Sector context
#106 of 204
Health Care
What the data says
At $-1.47, Arcellx, Inc.'s eps (diluted) ranks #106 of 204 in the Health Care sector. Improved from $-5.19 to $-1.47 over the past 2 years.
Based on SEC 10-K filings.
-1.47 in FY2025.
Improved from $-5.19 to $-1.47 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#106 of 204 in Health CareTop 52% of 204This company -$1.47 Sector average -$0.89
▼
-65.9% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 71.7% year-over-year.
- Ranks #106 out of 204 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.02 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.47 | +71.7% |
| FY2024 | -$5.19 | +0.0% |
| FY2023 | -$5.19 | +0.0% |
| FY2022 | -$5.19 | +96.4% |
| FY2021 | -$145.55 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026